Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119035) titled 'An Observational Study Exploring Invasive Markers of Pulmonary Nodules Based on Peripheral Blood DNA Methylation Detection Technology' on Feb. 14.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Peking University Cancer Hospital & Institute, Beijing
Condition:
Pulmonary nodules (diameter < 30 mm)
Intervention:
Gold Standard:Histopathological diagnosis is used as the primary gold standard. Malignant pulmonary nodules must be confirmed by pathology, and classified as adenocarcinoma in situ/minimally invasive adenocarcinoma (AIS/MIA) or invasive lung cancer according to...